Cencora, Inc. (NYSE:COR) Q3 2025 Earnings Call Transcript
Operator: Hello, everyone, and thank you for joining the Cencora Fiscal 2025 Third Quarter Results call. My name is Lucy, and I'll be coordinating your call today.
Cencora Inc. (COR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ayrshire Capital Management John Nevin Jr. | 20,308 | $6,346,826 | -1% | 2.95% |
| 2. | Sivik Global Healthcare Krishen Sud | 20,000 | $6,251 | -20% | 1.82% |
| 3. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $218.58 | 500 | $109,290.00 | 21,876 | 2024-05-24 | Filing | |
| $74.33 | 1,350 | $100,341.99 | 6,717 | 2020-03-23 | Filing | |
| $82.62 | 1,225 | $101,212.44 | 5,367 | 2020-03-13 | Filing | |
| $80.53 | 11 | $848.30 | 7,437 | 2019-03-05 | Filing | |
| $88.44 | 10 | $844.53 | 7,437 | 2018-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $326.80 | 5,097 | $1,665,699.60 | 37,940 | 2025-10-20 | Filing | |
| $313.28 | 1,886 | $590,846.08 | 12,824 | 2025-10-01 | Filing | |
| $290.00 | 5,097 | $1,478,130.00 | 39,274 | 2025-09-18 | Filing | |
| $289.86 | 31,350 | $9,087,142.35 | 305,913 | 2025-09-16 | Filing | |
| $289.98 | 14,579 | $4,227,618.42 | 307,913 | 2025-08-19 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,399,123 | $437,267,911 | 0.44% | |
| 2. | 423,706 | $132,098,828 | 0.21% | |
| 3. | 373,494 | $116,728,080 | 0.12% | |
| 4. | 353,021 | $110,329,653 | 0.15% | |
| 5. | 209,249 | $65,396,590 | 1.06% |
News See All
Cencora, Inc. (COR): A Bull Case Theory
We came across a bullish thesis on Cencora, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on COR.
Cencora, Inc. (COR): If It Was Down, I'd Say "Double Down And Buy," Says Jim Cramer
Cencora, Inc. (NYSE:COR) is an American pharmaceutical and healthcare services provider. It is a rare stock in its peers that is in the green this year. Cencora, Inc.
Jim Cramer's Fresh 14 Stocks & Thoughts About Market Performance
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed a JPMorgan note suggesting that its clients expected President Trump to be more accommodating when it came to market concerns...
Wells Fargo Upgrades Cencora (COR) Stock to Overweight, Lifts PT
On June 3, Wells Fargo analysts upgraded Cencora, Inc.
Robust Results Lifted Cencora (COR) Amid Upgraded Outlook
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Highlights Cencora (COR) "Knocked It Out of The Park"
We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where Cramer noted that while Cencora, Inc.
8 Stocks on Jim Cramer’s Radar Recently
On Wednesday’s episode of Mad Money, Jim Cramer reviewed the recent developments affecting drug distribution companies and laid out why he is turning cautious on the group.
Cencora, Inc. (NYSE:COR) Q2 2025 Earnings Call Transcript
Operator: Hello, everyone, and thank you for joining the Cencora Fiscal 2025 Second Quarter Results Conference Call. My name is Lucy, and I will be coordinating your call today.
Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks
In his recent appearance on CNBC's Squawk on the Street, Jim Cramer found his love for Magnificent 7 stocks once again.
Hedge Fund Resource Center Billionaire Hedge Funds
